Exencial Wealth Advisors LLC Reduces Position in Cigna Group $CI

Exencial Wealth Advisors LLC cut its stake in shares of Cigna Group (NYSE:CI) by 1.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,405 shares of the health services provider’s stock after selling 77 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in Cigna Group were worth $2,117,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in CI. Impact Investors Inc boosted its stake in shares of Cigna Group by 1.6% during the 1st quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock worth $650,000 after acquiring an additional 31 shares in the last quarter. Westend Capital Management LLC boosted its stake in shares of Cigna Group by 8.1% during the 1st quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock worth $140,000 after acquiring an additional 32 shares in the last quarter. Financial Network Wealth Advisors LLC boosted its stake in shares of Cigna Group by 26.8% during the 1st quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock worth $53,000 after acquiring an additional 34 shares in the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of Cigna Group by 1.0% during the 2nd quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock worth $1,137,000 after acquiring an additional 35 shares in the last quarter. Finally, Pure Portfolios Holdings LLC boosted its stake in shares of Cigna Group by 4.9% during the 1st quarter. Pure Portfolios Holdings LLC now owns 773 shares of the health services provider’s stock worth $254,000 after acquiring an additional 36 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $365.00 target price on shares of Cigna Group in a research note on Tuesday, August 26th. Wells Fargo & Company upped their price target on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 7th. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a research report on Thursday, August 14th. Royal Bank Of Canada restated an “outperform” rating and set a $371.00 price target on shares of Cigna Group in a research report on Thursday, June 26th. Finally, Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average target price of $369.89.

Cigna Group Trading Up 0.3%

Shares of Cigna Group stock opened at $308.30 on Thursday. The stock has a market cap of $82.30 billion, a P/E ratio of 16.83, a P/E/G ratio of 0.90 and a beta of 0.45. The stock’s 50 day simple moving average is $298.83 and its 200-day simple moving average is $307.81. Cigna Group has a 1-year low of $256.89 and a 1-year high of $350.00. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Thursday, December 4th. Cigna Group’s payout ratio is currently 32.97%.

Insider Activity at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.